icon-account icon-glass
Welcome to POINT OF RETURN
Connect

Desvenlafaxine Withdrawal and Tapering Help

Desvenlafaxine has higher rates of withdrawal symptoms (discontinuation syndrome) than other SNRI or SSRI antidepressants, and class action lawsuits against Wyeth have been filed for failing to reveal the truth.  Its important to taper slowly. Our NonProfit has been helping people withdraw safely for over 14 Years.  Contact the Prescription Drug Experts for help.

Desvenlafaxine (Pristiq) was approved by the FDA in 2007 (for Wyeth Laboratories) and is the active metabolite of Venlafaxine (Effexor), which lost its patent protection the same year. Desvenlafaxine was approved in Canada and the United States. Desvenlafaxine has higher rates of withdrawal symptoms (discontinuation syndrome) than other SNRI or SSRI antidepressants. For some patients the symptoms can be severe and are considered intolerable. A gradual taper is recommended to minimize symptoms. Desvenlafaxine is the active metabolite of Venlafaxine and can have significant withdrawal symptoms.  Contact Us if you need help tapering Desvenlafaxine or have questions.

Click here   for more information and history of Desvenlafaxine.

call us

Real Results for Desvenlafaxine Dependency

The Point of Return Program is an in-home tapering program that allows you to gradually lessen the amount of Desvenlafaxine while also implementing the use of all-natural, calming nutraceuticals to help ease symptoms. We eliminate Interaction items to help make Desvenlafaxine withdrawal more comfortable. Our physician recommended schedules allow your doctor to taper you off Desvenlafaxine correctly.  The success of our program over the past 14 years is due to our unmatched service and unique mentoring approach. Desvenlafaxine is dangerous to abruptly or rapidly stop and our program is a proven, viable, low-cost option to continue living your life while tapering. Read program FAQ page.

We are prescription drug experts that specialize in Antidepressant withdrawals.

We've helped people in 76 counties and in all 50 states of the USA

PROVEN RESULTS

This is a low cost program with proven results. So don't suffer...

Here I am, at the other side.  I've returned to my life but it's better than it was before because I have such gratitude and appreciation for all that I have. more...

- Suzy L., (Canada) Pristiq (Desvenlafaxine)

Key Components of Our In-Home Program

  • Skilled Experts in Prescription Drugs guiding you throughout the process.
  • Professional, kind mentoring
  • Assessment at the onset to determine taper rates, potential interactions, etc.
  • *Nutraceuticals specially formulated to ease symptoms, these are utilized throughout the whole process
  • Unlike herbs and many vitamins, our nutraceuticals will not interact with any medications
  • Information, advice and direction
  • 24/7 discussion board with encouraging members and knowledgeable mentors
  • Email and phone access at no charge
  • Recommendations for addressing symptoms such as gut problems, headaches, pain, etc.
  • Experienced team of committed experts with over 14 years experience
  • Every person at Point of Return has a personal story with these drugs. You are never alone

    Call toll-free 866-605-2333 to Learn More or send us an Email.

Withdrawal Symptoms May Include

aggression, anxiety, balance issues , blurred vision, brain zaps, concentration impairment, constipation, crying spells, depersonalization, diarrhea, dizziness. electric shock sensations, fatigue, flatulence, flu-like symptoms, hallucinations, hostility, highly emotional, indigestion, irritability, impaired speech, insomnia, jumpy nerves, lack of coordination, lethargy, migraine headaches / increased headaches, nausea, nervousness, over-reacting to situations, paranoia, repetitive thoughts or songs, sensory & sleep disturbances, severe internal restlessness (akathisia), stomach cramps, tremors, tinnitus (ear ringing or buzzing), tingling sensations, troubling thoughts, visual hallucinations / illusions, vivid dreams, speech or visual changes, worsened depression

Side Effects

allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives), irregular heartbeat or pulse, low blood pressure (dizziness, weakness), high blood pressure (severe headache, blurred vision), chills or fever, unusual bleeding or bruising, rash or hives, Suicidal Ideation, Headache, tremor, nervousness, or anxiety; difficulty concentrating, constipation, nausea, diarrhea, dry mouth, or changes in appetite or weight, weakness, increased sweating, sleeping or insomnia, decreased sex drive, impotence, or difficulty having an orgasm

Other Names for Desvenlafaxine Include: 

Pristiq

Break Free Today

At Point of Return, a 501(c)3 nonprofit, we have spent the last 14 years helping people taper off antidepressants correctly. With customized taper rates and all natural nutraceuticals, our program allows you to control your symptoms and properly come off Desvenlafaxine, once and for all, from the comfort of your home. Read program FAQs.

Freedom

" My heartfelt thanks to all of the POINT OF RETURN team – the group of participants that provide emotional support on the forum – and most of all – to Alesandra." - Kellia A. (Canada) more...

reach out for help

Message sent, thanks!

Desvenlafaxine history and info

Desvenlafaxine was approved by the FDA in 2007 (for Wyeth Laboratories) and is the active metabolite of Venlafaxine (Effexor), which lost its patent protection the same year. Desvenlafaxine was approved in Canada and the United States, but the European Union declined stating in part, "they had some concerns and was of the provisional opinion that Desvenlafaxine could not have been approved for the treatment of major depressive disorder [and] overall, the effectiveness of Desvenlafaxine had not been shown convincingly. In relation to its parent substance, Venlafaxine, Desvenlafaxine seemed to be less effective with no advantages in terms of safety and tolerability." Wyeth withdrew its application for approval in the European Union.

In December 2015 Pfizer announced the results from a Phase 3 study evaluating the efficacy, safety and tolerability of Pristiq (sustained release) in pediatric patients ages 7-17 with Major Depressive Disorder. The results indicate that Pristiq (Desvenlafaxine) were not significantly different from placebo.

Desvenlafaxine has higher rates of withdrawal symptoms (discontinuation syndrome) than other SNRI or SSRI antidepressants. For some patients the symptoms can be severe and are considered intolerable. A gradual taper is recommended to minimize symptoms.

Desvenlafaxine is the active metabolite of Venlafaxine and can have significant withdrawal symptoms.

Back to top of page

DISCLAIMER:

*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.

*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More...